Corlieve Therapeutics
Latest round
- Series A
Last raised
- Oct 2020
Total raised
- $6.7M
Investors
- 5
About Corlieve Therapeutics
Founded in 2019 and headquartered in Paris, France, Corlieve Therapeutics SAS specializes in gene therapies for neurological disorders.V.3 million from BB Pureos Bioventures and others, marking a strategic pivot in its business operations. The acquisition positions Corlieve within a robust portfolio aimed at expanding innovative treatment options.Corlieve Therapeutics SAS develops a range of gene therapies specifically designed to target neurological disorders. Their innovative approach utilizes miRNA silencing technology to create effective treatments.V. The acquisition will also support its expansion into new markets, including North America and Asia, by enhancing its global leadership in gene therapy. The company aims to introduce new therapeutic products targeting various neurological conditions by 2025, aiming for substantial advancements in treatment options available to patients.
Who invested in Corlieve Therapeutics
5 investors across 2 rounds
See all investors in Corlieve Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Corlieve Therapeutics
Who invested in Corlieve Therapeutics?
Corlieve Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Corlieve Therapeutics raised?
Corlieve Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Corlieve Therapeutics last raise money?
Corlieve Therapeutics's most recent round on record is a Series A, in Oct 2020.
What does Corlieve Therapeutics do?
Founded in 2019 and headquartered in Paris, France, Corlieve Therapeutics SAS specializes in gene therapies for neurological disorders.
Where is Corlieve Therapeutics headquartered?
Corlieve Therapeutics is headquartered in Paris, France.
Which VCs invest in companies like Corlieve Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Corlieve Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Corlieve Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.